Teva Pharmaceutical Indus...

NYSE: TEVA · Real-Time Price · USD
16.95
0.01 (0.06%)
At close: May 23, 2025, 3:59 PM
17.00
0.32%
After-hours: May 23, 2025, 05:42 PM EDT

Teva Pharmaceutical Industries Statistics

Share Statistics

Teva Pharmaceutical Industries has 1.15B shares outstanding. The number of shares has increased by 1.17% in one year.

Shares Outstanding 1.15B
Shares Change (YoY) 1.17%
Shares Change (QoQ) 0.99%
Owned by Institutions (%) 58.69%
Shares Floating n/a
Failed to Deliver (FTD) Shares 1,224
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 28.43M, so 2.48% of the outstanding shares have been sold short.

Short Interest 28.43M
Short % of Shares Out 2.48%
Short % of Float 2.49%
Short Ratio (days to cover) 2.82

Valuation Ratios

The PE ratio is -15.21 and the forward PE ratio is 6.01. Teva Pharmaceutical Industries's PEG ratio is -0.08.

PE Ratio -15.21
Forward PE 6.01
PS Ratio 1.51
Forward PS 1.2
PB Ratio 4.63
P/FCF Ratio 33.28
PEG Ratio -0.08
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Teva Pharmaceutical Industries.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 3.36.

Current Ratio 0.98
Quick Ratio 0.75
Debt / Equity 3.36
Debt / EBITDA 25.25
Debt / FCF 24.14
Interest Coverage -0.3

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $447,135.14
Profits Per Employee $-44,297.3
Employee Count 37,000
Asset Turnover 0.42
Inventory Turnover 2.82

Taxes

Income Tax 676M
Effective Tax Rate -52.65%

Stock Price Statistics

The stock price has increased by 1.13% in the last 52 weeks. The beta is 0.63, so Teva Pharmaceutical Industries's price volatility has been higher than the market average.

Beta 0.63
52-Week Price Change 1.13%
50-Day Moving Average 15.55
200-Day Moving Average 17.53
Relative Strength Index (RSI) 56.57
Average Volume (20 Days) 12,431,270

Income Statement

In the last 12 months, Teva Pharmaceutical Industries had revenue of 16.54B and earned -1.64B in profits. Earnings per share was -1.45.

Revenue 16.54B
Gross Profit 8.06B
Operating Income -303M
Net Income -1.64B
EBITDA 716M
EBIT -282M
Earnings Per Share (EPS) -1.45
Full Income Statement

Balance Sheet

The company has 3.3B in cash and 18.08B in debt, giving a net cash position of -14.78B.

Cash & Cash Equivalents 3.3B
Total Debt 18.08B
Net Cash -14.78B
Retained Earnings -15.17B
Total Assets 38.41B
Working Capital 371M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.25B and capital expenditures -498M, giving a free cash flow of 749M.

Operating Cash Flow 1.25B
Capital Expenditures -498M
Free Cash Flow 749M
FCF Per Share 0.66
Full Cash Flow Statement

Margins

Gross margin is 48.74%, with operating and profit margins of -1.83% and -9.91%.

Gross Margin 48.74%
Operating Margin -1.83%
Pretax Margin -7.76%
Profit Margin -9.91%
EBITDA Margin 4.33%
EBIT Margin -1.83%
FCF Margin 4.53%

Dividends & Yields

TEVA pays an annual dividend of $1.19, which amounts to a dividend yield of 5.8%.

Dividend Per Share $1.19
Dividend Yield 5.8%
Dividend Growth (YoY) 0%
Payout Ratio -103.48%
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for TEVA is $24.5, which is 44.5% higher than the current price. The consensus rating is "Buy".

Price Target $24.5
Price Target Difference 44.5%
Analyst Consensus Buy
Analyst Count 6
Stock Forecasts

Stock Splits

The last stock split was on Jul 1, 2004. It was a forward split with a ratio of 2:1.

Last Split Date Jul 1, 2004
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 0.31
Piotroski F-Score 6